Grants and Contributions:
Title:
Gut Health Check Analysis Kit Development
Agreement Number:
952572
Agreement Value:
$50,000.00
Agreement Date:
Jul 6, 2020 - Mar 31, 2021
Description:
Digestive disorders are observed in 20 million Canadians every year. Moreover, it costs 18 bn dollars to the Canadian economy. Nucliq Biologics Inc (NBI) incorporated in April 2019 provides services to reveal the gut microbial diversity for the patients suffering with dysbiosis (gut microbial imbalance), gastrointestinal problems, obesity, and other gut-related diseases. NBI performs tests to uncover the gut microbiome and provides a detailed gut microbial richness report and counseling related to gut health, food, nutrition and bacterial composition to improve patient’s health.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
St. John's, Newfoundland & Labrador, CA A1B 4B8
Reference Number:
172-2020-2021-Q1-952572
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
755204930
Recipient Type:
For-profit organization
Recipient's Operating Name:
Nucliq Bio
Recipient's Legal Name:
Nucliq Biologics Inc.
Federal Riding Name:
St. John's East
Federal Riding Number:
10006
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
334512